Literature DB >> 17235657

Autonomic dysfunction and microvascular damage in systemic sclerosis.

Manuela Di Franco1, Michele Paradiso, Valeria Riccieri, Stefania Basili, Antonio Mammarella, Guido Valesini.   

Abstract

Systemic sclerosis (SSc) is a connective tissue disease characterized by vascular damage and interstizial fibrosis of many organs. Our interest was focused on the evaluation of cardiac autonomic function by measurements of heart rate variability (HRV) and microvascular damage detected by nailfold capillaroscopy (NC) in SSc patients. We examined 25 consecutive outpatients affected by systemic sclerosis and 25 healthy controls. Exclusion criteria were the presence of cardiac disease, hypertension, diabetes mellitus, or neurological diseases. All subjects underwent 24-h ambulatory ECG Holter recording and NC examination. Heart rate variability was evaluated in the time domain, using appropriate software, computing the time series of all normal-to-normal (NN) QRS intervals throughout the 24-h recording period. A semiquantitative rating scale was adopted to score the NC abnormalities, as well as a rating system for avascular areas and morphological NC patterns. In SSc patients, HRV analysis showed significantly lower values of SDNN (standard deviation of all NN intervals) (p=0.009), SDANN (standard deviation of the averages of NN intervals in all 5-min segments of the entire recording) (p=0.01), and pNN50 (the percentage of adjacent NN intervals that differed by more than 50 ms) (p=0.02), compared to the control group. These parameters in SSc patients significantly decreased with the worsening of semiquantitative capillaroscopy score. In conclusion, an abnormal autonomic nervous control of the heart might contribute to identify subclinical cardiac involvement in SSc patients. The coexistence of autonomic dysfunction with a more severe microvascular damage could be considered a potential prognostic tool in the identification of those patients particularly at risk for cardiac mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17235657     DOI: 10.1007/s10067-006-0492-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls.

Authors:  Y Kabasakal; D M Elvins; E F Ring; N J McHugh
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

2.  Twenty-four hour heart period variability in systemic sclerosis.

Authors:  S Morelli; G Piccirillo; F Fimognari; A Sgreccia; L Ferrante; G Morabito; P De Marzio; G Valesini; V Marigliano
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

3.  Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease.

Authors:  G Stacher; R Merio; C Budka; C Schneider; J Smolen; G Tappeiner
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

4.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

5.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

Review 6.  Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone.

Authors:  B Kahaleh; M Matucci-Cerinic
Journal:  Arthritis Rheum       Date:  1995-01

7.  Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.

Authors:  H Tsuji; F J Venditti; E S Manders; J C Evans; M G Larson; C L Feldman; D Levy
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities.

Authors:  V Riccieri; T Rinaldi; A Spadaro; R Scrivo; F Ceccarelli; M Di Franco; E Taccari; G Valesini
Journal:  Clin Rheumatol       Date:  2003-05       Impact factor: 2.980

10.  Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.

Authors:  P Pancera; S Sansone; B Presciuttini; L Montagna; S Cerù; C Lunardi; A Lechi
Journal:  Clin Sci (Lond)       Date:  1999-01       Impact factor: 6.124

View more
  14 in total

1.  Evaluation of arterial stiffness and hemodynamics by oscillometric method in patients with systemic sclerosis.

Authors:  Murat Sunbul; Kursat Tigen; Gulsen Ozen; Erdal Durmus; Tarik Kivrak; Altug Cincin; Alper Kepez; Halil Atas; Haner Direskeneli; Yelda Basaran
Journal:  Wien Klin Wochenschr       Date:  2013-07-12       Impact factor: 1.704

2.  Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical case.

Authors:  Fabio Marsico; Gianluigi Savarese; Celestino Sardu; Cristoforo D'Ascia; Donatella Ruggiero; Laura Casaretti; Valentina Parisi; Francesca Musella; Elisabetta Pirozzi; Roberto Formisano; Teresa Losco; Pasquale Perrone Filardi
Journal:  J Cardiol Cases       Date:  2012-03-31

3.  Cardiac mechanics and heart rate variability in patients with systemic sclerosis: the association that we should not miss.

Authors:  Maja Zlatanovic; Marijana Tadic; Vera Celic; Branislava Ivanovic; Ana Stevanovic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2016-11-25       Impact factor: 2.631

4.  Anti-exudation effects of sodium ferulate and oxymatrine combination via modulation of aquaporin 1.

Authors:  Songmei Sun; Xing Du; Mengxin Xu; Meijuan Liu; Zhifeng Liu
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

5.  Noninvasive evaluation of cardiac autonomic modulation in children with primary Raynaud’s phenomenon: a controlled study.

Authors:  Mehmet Burhan Oflaz; İbrahim Ece; Ayşe Esin Kibar; Şevket Ballı; Demet Alaygut; Ahmet Sami Guven; Fatih Bolat; Fatma Duksal; Ömer Cevit
Journal:  Clin Rheumatol       Date:  2014-01       Impact factor: 2.980

6.  Impact of systemic sclerosis on electromechanical characteristics of the heart.

Authors:  Tansu Karaahmet; Kursat Tigen; Emre Gurel; Mumtaz Takir; Anil Avci; Cihan Cevik; Selcuk Pala; Cihan Dundar; Yelda Basaran
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

7.  Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients.

Authors:  Francesco Masini; Raffaele Galiero; Pia Clara Pafundi; Klodian Gjeloshi; Emanuele Pinotti; Roberta Ferrara; Ciro Romano; Luigi Elio Adinolfi; Ferdinando Carlo Sasso; Giovanna Cuomo
Journal:  J Scleroderma Relat Disord       Date:  2021-06-07

8.  Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire.

Authors:  Brittany L Adler; James W Russell; Laura K Hummers; Zsuzsanna H McMahan
Journal:  J Rheumatol       Date:  2018-06-15       Impact factor: 4.666

Review 9.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

10.  Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients - a 24-month observation.

Authors:  Ewa Wielosz; Maria Majdan; Arkadiusz Koszarny; Magdalena Dryglewska; Jacek Tabarkiewicz
Journal:  Cent Eur J Immunol       Date:  2017-08-08       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.